Institutional investors purchased a net $995.7 thousand shares of BCYC during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 73.15% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST LIGHT ASSET MANAGEMENT LLC Bought 1.0 Million shares of Bicycle Therapeutics PLC